UPDATE 1-Exelixis and Pfizer drugs compete in kidney cancer trial
October 10, 2016 at 03:32 AM EDT
* Pfizer's Sutent helps patients after kidney cancer surgery (Adds Exelixis planning to seek approval based on study results)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.